{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:06:24Z","timestamp":1790334384341,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.vaccine.2009.02.069","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T09:44:13Z","timestamp":1236159853000},"page":"2899-2904","source":"Crossref","is-referenced-by-count":44,"title":["Characterization of neutralizing antibodies to Far Eastern of tick-borne encephalitis virus subtype and the antibody avidity for four tick-borne encephalitis vaccines in human"],"prefix":"10.1016","volume":"27","author":[{"given":"Galina N.","family":"Leonova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Pavlenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2009.02.069_bib1","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1469-0691.2004.01022.x","article-title":"Tick-borne virus diseases of human interest in Europe","volume":"10","author":"Charrel","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2009.02.069_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1099\/0022-1317-80-1-179","article-title":"Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia","volume":"80","author":"Ecker","year":"1999","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib3","first-page":"14","article-title":"Tick-borne encephalitis virus, the genetic characteristic and variability in modern world","volume":"4","author":"Loktev","year":"2007","journal-title":"Byull SO RAMSci"},{"key":"10.1016\/j.vaccine.2009.02.069_bib4","first-page":"272","article-title":"Molecular Epidemiology of tick-borne encephalitis","author":"Zlobin","year":"2003","journal-title":"Irkutsk: RIO VSNTs SO RAMSci"},{"key":"10.1016\/j.vaccine.2009.02.069_bib5","first-page":"201","article-title":"Tick-borne encephalitis and the impact of vaccination","volume":"18","author":"Heinz","year":"2004","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib6","series-title":"Vaccine Prevention of Tick-Borne Encephalitis","author":"Leonova","year":"2006"},{"key":"10.1016\/j.vaccine.2009.02.069_bib7","doi-asserted-by":"crossref","unstructured":"Kunz C. TBE vaccination and Austrian experience. Vaccine 2003;21:S1\/50\u201355.","DOI":"10.1016\/S0264-410X(02)00813-7"},{"key":"10.1016\/j.vaccine.2009.02.069_bib8","first-page":"22","article-title":"An experience in realizing programs of mass population immunization against tick-borne encephalitis in Sverdlovsk oblast","volume":"6","author":"Romanenko","year":"2007","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib9","first-page":"30","article-title":"Vaccine, immunoglobulin, and test kits for prevention and diagnostics of tick-borne encephalitis","volume":"6","author":"Vorobyova","year":"2007","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0264-410X(92)90376-U","article-title":"Molecular epidemiology of tick-borne-encephalitis virus: cross-protection between European and Far Eastern subtypes","volume":"10","author":"Holzmann","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.02.069_bib11","first-page":"1","article-title":"Epidemiology of tick-borne encephalitis (TBE) and phylogenetic analysis of TBE viruses in Japan and Far Eastern Russia","volume":"54","author":"Takashima","year":"2001","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2009.02.069_bib12","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.3201\/eid1310.070158","article-title":"Novel variant of tick-borne encephalitis virus, Russia","volume":"13","author":"Ternovoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2009.02.069_bib13","first-page":"10","article-title":"Molecular genetic characterization of tick-borne encephalitis virus","volume":"5","author":"Loktev","year":"2007","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib14","first-page":"16","article-title":"The evolution of tick-borne encephalitis and the problem of the pathogen evolution","volume":"5","author":"Pogodina","year":"2007","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib15","first-page":"57","article-title":"Comparative studying immunogenicity of vaccines against tick-borne encephalitis","volume":"11","author":"Pavlenko","year":"2007","journal-title":"Far Eastern J Infect Pathol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib16","first-page":"29","article-title":"The avidity index of specific IgG in the diagnosis of diseases caused by West Nile and tick-borne encephalitis viruses","volume":"7","author":"Raspopin","year":"2007","journal-title":"Clin Lab Diagn"},{"key":"10.1016\/j.vaccine.2009.02.069_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.vaccine.2006.09.014","article-title":"Evaluation of vaccine Encepur\u00ae Adult for induction of human neutralizing antibodies against recent Far Eastern subtype strains of tick-borne encephalitis","volume":"25","author":"Leonova","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.02.069_bib18","first-page":"19","article-title":"Analysis of the efficiency of tick-borne encephalitis vaccination in the population in the natural foci of Austria","volume":"53","author":"Heinz","year":"2008","journal-title":"Vopr Virusol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib19","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.00284-06","article-title":"Characterization of antibody responses to combinations of a Dengue virus type 2 DNA vaccine and two Dengue virus type 2 protein vaccines in rhesus macaques","volume":"10","author":"Simmons","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1128\/CVI.13.1.33-36.2006","article-title":"Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus","volume":"1","author":"Fox","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/JCM.20.3.525-529.1984","article-title":"Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed","volume":"9","author":"Inouye","year":"1984","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib22","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1128\/JCM.40.11.4015-4020.2002","article-title":"Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method","volume":"11","author":"Suligoi","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.02.069_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1128\/JCM.01243-06","article-title":"Evaluation of commercial rubella immunoglobulin G avidity assays","volume":"1","author":"Mubareka","year":"2007","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09003211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T08:49:27Z","timestamp":1589618967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09003211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":23,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0264410X09003211"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.02.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}